Xcout IntelEmpirico Inc.
Empirico Inc. is a drug discovery and development company headquartered in San Diego, California. It utilizes large biological datasets, human genetics, and programmable biology to discover novel therapeutics.
Subscribe to see Empirico Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Empirico Inc. at a glance
Empirico Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $45.2M in March 2023. Xcout tracks 1 named person at Empirico Inc., including Barry Hess (Designer / Founder).
Empirico Inc. leadership
- Barry HessDesigner / Founder
Empirico Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $45.2M | — | |
| Undisclosed round | $45.2M | — | |
| Series A | $17M | 1 named | |
| SEC Form D filing | $12.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Empirico Inc. competitors
A few of Empirico Inc.'s closest competitors — see the full list of competitors and alternatives →
ProNovo Therapeutics is a precision medicine company headquartered in San Diego, California, focused on developing targeted therapeutics.
Sinopia Biosciences, Inc. is a privately held biotechnology company headquartered in San Diego, California. Founded in 2014, the company focuses on advancing novel therapeutics discovered through its proprietary computational drug discovery platform.
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Actio Biosciences, Inc. is a biotechnology research company headquartered in San Diego, California, United States. It leverages advances in genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare diseases.
Enspire Bio, Inc. is a drug discovery company founded in 2017 with the goal of bridging industry with cutting-edge academic research. The company operates in the biotechnology sector within the United States.
Get Empirico Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Empirico Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Empirico Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access